Efficacy and safety of luseogliflozin in Caucasian patients with type 2 diabetes: results from a phase III, randomized, placebo-controlled, clinical trial

Marina Shestakova; Boris Kvasnikov; Ekaterina Erina; Elena Isachenko; Alexander Andreev

doi:10.1136/bmjdrc-2022-003290

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF

PDF +
Supplementary
Material

Cardiovascular and metabolic risk

Efficacy and safety of luseogliflozin in Caucasian patients with type 2 diabetes: results from a phase III, randomized, placebo-controlled, clinical trial

	Abstract	Full	Pdf
Jul 2023	430	430	146
Aug 2023	277	281	59
Total	707	711	205

Main menu

Online download statistics by month:

Online download statistics by month: July 2023 to August 2023

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online download statistics by month:

Online download statistics by month: July 2023 to August 2023

Read the full text or download the PDF:

Log in using your username and password